Nina Khanna

Nov 7, 2024 | nature.com | Nina Khanna |Jiang Lin |Xu Liu

AbstractChina, the world’s largest methane emitter, is increasingly focused on methane mitigation in support of its climate goals, but gaps exist in the understanding of key methane sources, as well as mitigation opportunities and their associated uncertainties. We use a bottom-up modeling approach with updated methane emission projections and abatement cost analysis to account for additional sources, uncertainties, and mitigation measures in China’s energy and agricultural sectors.

Jul 5, 2024 | onlinelibrary.wiley.com | Dionysios Neofytos |Nina Khanna

1 INTRODUCTION Immunocompromised patients face a higher risk of developing severe coronavirus disease 2019 (COVID-19), with differences according to the immunosuppressive condition.1 This particularly vulnerable patient population with admittedly variable degrees and severity of immunosuppression may display lower responsiveness rates to vaccines and have been markedly underrepresented in clinical trials for COVID-19.2–4 Yet, immunocompromised patients represent around 3% of the US population...

Jan 3, 2024 | nature.com | Marek Basler |Petr Broz |Knut Drescher |Alexander Harms |Andreas Hierlemann |Sebastian Hiller | +11 more

In vitro models mimicking in-patient conditions have the potential to yield exciting opportunities for antibiotic research and revitalize future antibiotic discovery and development. Antibiotics have revolutionized modern medicine. However, their usefulness in treating bacterial infections and as prophylactics accompanying chemotherapy or surgery is under threat by the rise of antibiotic-resistant bacteria.